Heptagon Pharma - B [02142] is currently reported at HKD 3.28, an increase of 10.07%.

As of 15:16, Hanrich Pharmaceuticals - B [02142] is quoted at 3.28 Hong Kong dollars, up 0.3 Hong Kong dollars or 10.07% from yesterday's closing price of 2.98 Hong Kong dollars, with a turnover of 16.4047 million Hong Kong dollars. Today's highest price is 3.28 Hong Kong dollars and the lowest price is 2.97 Hong Kong dollars. Based on yesterday's closing price, the 10-day average is 2.67 Hong Kong dollars, the 50-day average is 1.63 Hong Kong dollars, and the current PE is 12.28 times, with a 14-day RSI of 81.11.

Jinwu Financial NewsJan 22 02:16 ET

Hong Kong stock movement | HBM HOLDINGS-B (02142) rose over 7% again, recently reaching approximately 1 billion dollars in overseas cooperation. At the beginning of the month, a 40 million Hong Kong dollar buyback plan was announced.

HBM HOLDINGS-B (02142) has soared over 7% again, reaching a new high of 3.06 HKD, the highest since February 2023, with the stock price increasing more than 1.6 times in the past month. As of the time of this report, it has risen 7.04% to 3.04 HKD, with a trading volume of 7.5789 million HKD.

Zhitong FinanceJan 16 21:08 ET

On January 16, HBM HOLDINGS-B (02142) spent 1.5894 million HKD to repurchase 0.6 million shares.

HBM HOLDINGS-B (02142) announced that on January 16, 2025, the company will invest 158.94...

Zhitong FinanceJan 16 07:35 ET

【Brokerage Focus】BOCOM INTL points out that Innovative Drugs companies continue the trend of going abroad, and is bullish on the Sector, which still has significant room for recovery.

Jinwu Finance | BOCOM INTL stated that in the new year, Chinese Innovative Drugs companies continue the trend of going abroad. INNOVENT BIO (01801), SIMCERE PHARMA (02096), Kangnuo Ya (02162), Kelun Botai (06990) / HeBo Pharma (02142), Ying'en Bio and other companies successfully licensed their Innovative Drug Assets through MNC big pharma or through NewCo format. The bank believes that going abroad will remain one of the biggest highlights of the Innovative Drugs Sector in 2025, and more significant Trades are worth looking forward to. In combination with previous drug and medical equipment procurement continuously creating funding space for medical insurance payments of innovative varieties, subsequent finance and medical insurance/business.

Jingu Financial NewsJan 15 20:12 ET

HBM HOLDINGS-B (02142.HK) spent 1.214 million Hong Kong dollars to repurchase 0.469 million shares on January 15.

Gelonghui, January 15 - HBM HOLDINGS-B (02142.HK) announced that on January 15, it spent 1.214 million HKD to repurchase 0.469 million shares.

Gelonghui FinanceJan 15 09:06 ET

HBM HOLDINGS-B (02142.HK) spent 0.099 million HKD to buy back 0.038 million shares on January 14.

Gelonghui, January 14 - HBM HOLDINGS-B (02142.HK) announced that on January 14, it spent 0.099 million Hong Kong dollars to repurchase 0.038 million shares.

Gelonghui FinanceJan 14 09:50 ET